Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Revenue (2020 - 2025)

Historic Revenue for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • Bolt Biotherapeutics' Revenue rose 9009.64% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 4687.6%. This contributed to the annual value of $7.7 million for FY2024, which is 236.16% down from last year.
  • Latest data reveals that Bolt Biotherapeutics reported Revenue of $2.2 million as of Q3 2025, which was up 9009.64% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Bolt Biotherapeutics' Revenue registered a high of $5.3 million during Q1 2024, and its lowest value of $508000.0 during Q4 2021.
  • Moreover, its 5-year median value for Revenue was $1.4 million (2022), whereas its average is $1.7 million.
  • Its Revenue has fluctuated over the past 5 years, first soared by 18882.8% in 2024, then tumbled by 7682.97% in 2025.
  • Quarter analysis of 5 years shows Bolt Biotherapeutics' Revenue stood at $508000.0 in 2021, then skyrocketed by 177.76% to $1.4 million in 2022, then soared by 48.05% to $2.1 million in 2023, then plummeted by 45.38% to $1.1 million in 2024, then skyrocketed by 90.1% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $1.8 million for Q2 2025, and $1.2 million during Q1 2025.